A NOVEL MARKER IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

被引:0
作者
Alp, G. T. [1 ]
Karadeniz, H. [2 ]
Vasi, I. [2 ]
Guler, A. Avanoglu [2 ]
Erden, A. [2 ]
Kucuk, H. [2 ]
Gulbahar, O. [3 ]
Tufan, A. [2 ]
Ozturk, M. A. [2 ]
机构
[1] Gazi Univ, Internal Med, Fac Med, Ankara, Turkiye
[2] Gazi Univ, Rheumatol, Fac Med, Ankara, Turkiye
[3] Gazi Univ, Med Biochem, Fac Med, Ankara, Turkiye
关键词
Biomarkers; Systemic sclerosis; Lungs; PULMONARY-FIBROSIS; KL-6;
D O I
10.1136/annrheumdis-2023-eular.5931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0845
引用
收藏
页码:1635 / 1636
页数:2
相关论文
共 4 条
  • [1] Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease
    Elko, Evan A.
    Cunniff, Brian
    Seward, David J.
    Chia, Shi Biao
    Aboushousha, Reem
    van de Wetering, Cheryl
    van der Velden, Jos
    Manuel, Allison
    Shukla, Arti
    Heintz, Nicholas H.
    Anathy, Vikas
    van der Vliet, Albert
    Janssen-Heininger, Yvonne M. W.
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2019, 31 (14) : 1070 - 1091
  • [2] Kumánovics G, 2008, CLIN EXP RHEUMATOL, V26, P414
  • [3] Yamane K, 2000, J RHEUMATOL, V27, P930
  • [4] Yanaba K, 2004, J RHEUMATOL, V31, P1112